Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tarazi, Shadi
GBT021601-021, NCT05431088: A Phase 2/3 Study in Adult and Pediatric Participants With SCD	Active, not recruiting	2/3	429	Europe, US, RoW	Osivelotor, PF-07940367 or GBT021601	Pfizer, Pfizer	Sickle Cell Disease	10/28	10/28